Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  olaratumab
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 15677, NCI-2015-01298, 2015-000134-30, I5B-MC-JGDJ, NCT02451943
A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 16 and over
Trial IDs: 15839, NCI-2016-00652, 2015-001316-34, I5B-MC-JGDL, NCT02659020
A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer
Status: Not yet active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: Under 18
Trial IDs: 15841, NCI-2016-00660, I5B-MC-JGDN, NCT02677116
Start Over